Screener
AngioDynamics ANGO Med Tech — Gross Profit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| (in thousands) | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Med Tech Net Sales | $149,954 | $126,653 | $106,403 |
| Med Tech Cost of Sales (exclusive of intangible amortization) | $54,598 | $48,138 | $39,205 |
| Gross Margin | $95,356 | $78,515 | $67,198 |
| Gross Margin % | 63.6% | 62.0% | 63.2% |
| Med Device Net Sales | $170,220 | $165,845 | $197,511 |
| Med Device Cost of Sales (exclusive of intangible amortization) | $90,684 | $86,655 | $110,011 |
| Gross Margin | $79,536 | $79,190 | $87,500 |
| Gross Margin % | 46.7% | 47.7% | 44.3% |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's med tech — gross profit?
- AngioDynamics (ANGO) reported med tech — gross profit of $26.86M in Q1 2026.
- How has AngioDynamics's med tech — gross profit changed year-over-year?
- AngioDynamics's med tech — gross profit increased by 27.2% year-over-year, from $21.12M to $26.86M.
- What is the long-term trend for AngioDynamics's med tech — gross profit?
- Over 4 years (2022 to 2026), AngioDynamics's med tech — gross profit has grown at a 16.0% compound annual growth rate (CAGR), from $52.58M to $95.36M.
- What does med tech — gross profit mean?
- Gross profit for the Med Tech segment is calculated as net sales minus the direct costs of production and delivery. It serves as a primary indicator of the segment's ability to generate value from its core medical device offerings after covering manufacturing expenses. This metric is critical for evaluating the segment's fundamental profitability and pricing power in the competitive medical technology market.
Ask your AI about AngioDynamics's med tech — gross profit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude